LABCORP HOLDINGS INC. Quarterly Cost of Revenue in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Labcorp Holdings Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2014 to Q3 2024.
  • Labcorp Holdings Inc. Cost of Revenue for the quarter ending September 30, 2024 was $2.38B, a 7.8% increase year-over-year.
  • Labcorp Holdings Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $9.16B, a 13% increase year-over-year.
  • Labcorp Holdings Inc. annual Cost of Revenue for 2023 was $8.8B, a 7.87% increase from 2022.
  • Labcorp Holdings Inc. annual Cost of Revenue for 2022 was $8.16B, a 0.14% increase from 2021.
  • Labcorp Holdings Inc. annual Cost of Revenue for 2021 was $8.14B, a 9.77% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $9.16B $2.38B +$172M +7.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $8.99B $2.29B +$103M +4.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $8.89B $2.28B +$91.6M +4.19% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $8.8B $2.21B +$685M +44.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $8.11B $2.21B +$225M +11.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 $7.89B $2.19B +$211M +10.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $7.68B $2.19B -$479M -18% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $8.16B $1.53B +$1.2B +365% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $6.96B $1.98B -$697M -26% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-30
Q2 2022 $7.65B $1.98B -$595M -23.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $8.25B $2.67B +$104M +4.07% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $8.14B $328M -$2.26B -87.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $10.4B $2.68B +$340M +14.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $10.1B $2.58B +$568M +28.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-01
Q1 2021 $9.49B $2.56B +$467M +22.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $9.03B $2.58B +$452M +21.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $8.57B $2.34B +$226M +10.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $8.35B $2.01B -$48.6M -2.36% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $8.4B $2.1B +$94.3M +4.71% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $8.3B $2.13B +$118M +5.84% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $8.18B $2.11B +$69.8M +3.42% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $8.11B $2.06B +$25.7M +1.27% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $8.09B $2B -$67.8M -3.28% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $8.16B $2.02B +$87.5M +4.54% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $8.07B $2.04B +$204M +11.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $7.87B $2.03B +$281M +16.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $7.58B $2.07B +$368M +21.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $7.22B $1.93B +$49.6M +2.64% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $7.17B $1.84B +$211M +13% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 $6.96B $1.75B +$146M +9.12% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-27
Q1 2017 $6.81B $1.7B +$111M +6.95% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 $6.7B $1.88B +$318M +20.4% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $6.38B $1.63B +$73.9M +4.76% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $6.31B $1.6B +$108M +7.18% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $6.2B $1.59B +$423M +36.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q4 2015 $5.78B $1.56B +$3.49B Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $2.29B $1.55B +$572M +58.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $1.72B $1.5B +$549M +57.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $1.17B $1.17B -$2.64B -69.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $3.81B -$1.93B Oct 1, 2014 Dec 31, 2014 10-K/A 2016-03-01
Q3 2014 $981M Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 $948M Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 $3.81B Jan 1, 2014 Mar 31, 2014 10-K 2017-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.